SYDNEY NIDIFFER: Open Payments
NPI 1861101321 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,683 in 134 payments from 20 companies in 2025. Trend: 2023 $4,779 · 2024 $3,364 · 2025 $2,683
Food & beverage: $2,535Education: $148
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 3 | $289 |
| MAYNE PHARMA COMMERCIAL LLC | 21 | $276 |
| Regeneron Healthcare Solutions, Inc. | 10 | $264 |
| Janssen Biotech, Inc. | 13 | $255 |
| ABBVIE INC. | 20 | $250 |
| Amgen Inc. | 13 | $197 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $175 |
| GENZYME CORPORATION | 10 | $169 |
| UCB, Inc. | 8 | $163 |
| Incyte Corporation | 4 | $104 |
Products named: DUPIXENT, Zoryve, TREMFYA, SKYRIZI, OTEZLA, Bimzelx, OPZELURA, CIBINQO.
Industry payments across SC — which companies pay providers there.
